Fulgent Genetics, Inc.
NASDAQ:FLGT
22.02 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Fulgent Genetics, Inc. |
Symbool | FLGT |
Munteenheid | USD |
Prijs | 22.02 |
Beurswaarde | 667,133,334 |
Dividendpercentage | 0% |
52-weken bereik | 18.76 - 30.68 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Ming Hsieh |
Website | https://www.fulgentgenetics.com |
An error occurred while fetching data.
Over Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)